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In the Netherlands, there is an ongoing and unparalleled outbreak of Q fever. Rapid and reliable methods to
identify patients infected with Coxiella burnetii, the causative agent of Q fever, are urgently needed. We evaluated the
performance of different DNA extraction methods and real-time PCR assays that are in use in seven diagnostic or
reference laboratories in the Netherlands. A low degree of variation in the sensitivities of most of the developed
real-time PCR assays was observed. However, PCR assays amplifying short DNA fragments yielded better results
than those producing large DNA fragments. With regard to DNA extraction, the automated MagNA Pure Compact
system and the manual QIAamp DNA mini kit consistently yielded better results than either the MagNA Pure LC
system and NucliSens EasyMag (both automated) or the High Pure viral nucleic acid kit (manual). The present
study shows that multiple combinations of DNA extraction kits and real-time PCR assays offer equivalent solutions
to detect C. burnetii DNA in serum samples from patients suspected to have Q fever.
Q fever is a worldwide zoonosis caused by Coxiella burnetii,
an obligate intracellular bacterium (11). Whereas animals such
as sheep and goats are generally asymptomatic carriers, infec-
tion with C. burnetii in these animals may become manifest by
abortion. Although asymptomatic in 60% of infected per-
sons, C. burnetii can cause serious illness in humans. Q fever
can cause acute or chronic infection depending on the patient’s
condition or immune status. Acute Q fever may present as a
self-limiting flu-like atypical pneumonia accompanied by se-
vere headache and sometimes hepatitis. Approximately 5% of
all Q fever cases may progress in a chronic infection leading to
life-threatening endocarditis (1, 3, 5, 7–9). C. burnetii is highly
infectious and can survive for long periods in the environment.
Human outbreaks have been associated with farms, slaughter-
houses, and wind dispersion from farms where infected animals
were kept. Ticks and pets, including cats and dogs, have also been
demonstrated to be potential sources of Q fever (1, 4, 10).
Laboratory diagnosis of Q fever is usually performed by
serological methods such as the indirect immunofluorescence
assay (IFA), complement fixation test (CFT), or enzyme-
linked immunosorbent assay (ELISA), but these tests are of
limited use in the early phase of the disease, as it may take
up to 2 weeks for a detectable immune response to develop.
Several PCR-based diagnostic methods, such as conven-
tional PCR, nested PCR, or real-time PCR, have successfully
been applied for the direct detection of C. burnetii DNA in
clinical samples. The sequences targeted by these tests varied
from plasmids (QpH1 or QpRS) to chromosomal genes, such
as the isocitrate dehydrogenase gene (NADP) or the trans-
posase gene of the C. burnetii IS1111a insertion element (3, 4,
14–16). The multicopy IS1111a insertion element is present
in 20 copies in the genome of the C. burnetii Nine Mile
RSA493 strain. Copy numbers per isolate vary and can reach
up to 100 copies per genome (7). Due to the multicopy
nature of this DNA element, it provides a highly sensitive
target for detection of C. burnetii DNA in serum samples.
Furthermore, real-time PCR can be useful for diagnosis of
chronic Q fever, since in these patients C. burnetii DNA can be
detected in serum over long periods of time (3).
In the Netherlands, as of 2007, there is an unprecedented
and ongoing outbreak of Q fever (12, 17). At present, more
than 3,000 cases have been reported in the Netherlands. In
order to improve diagnosis for Q fever, medical microbiology
laboratories have implemented molecular methods to close the
diagnostic gap between onset of the disease and the presence
of specific antibodies in serum. The aim of this study was to
compare the performances of different DNA extraction meth-
ods and real-time PCR assays, all targeting the C. burnetii
IS1111a insertion element, that are being used in seven diag-
nostic or public health laboratories in the Netherlands.
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MATERIALS AND METHODS
Study design. The study was set up to separately assess the performances of
the DNA extraction methods and of the real-time PCR assays. The analytical
sensitivities of the different PCR methods were determined using a dilution
series of genomic DNA extracted from the Nine Mile strain (RSA493). The
concentration of the DNA was determined by UV measurements and adjusted to
approximately 50 fg/l. Three-fold serial dilutions (nine steps) were prepared in
duplicate. Each DNA sample was tested in duplicate, and thus four PCR results
were obtained per sample. Based on a genome size of 2 Mbp and the presence
of 20 IS1111a copies per Nine Mile genome, the starting dilution (9-fold) con-
tains approximately 50 target copies/l DNA. The samples were blinded. All
laboratories used a fixed amount of 5 l DNA in their PCRs according the
procedure of each individual laboratory (Table 1).
Furthermore, all laboratories received three serum samples to compare the
relative efficiencies of the different DNA extraction methods. Two Q fever-
positive clinical samples were actual clinical samples from patients suffering from
acute Q fever. The clinical samples were qualified based on the threshold cycle
(CT) value that was obtained during initial screening of the samples. Sample A
represents a strong positive sample, and sample B is on the lower end of the
normal range for positive samples and repeatedly tested positive. The third
sample (C) was a negative control.
All samples were provided in duplicate and blinded such that the person
handling the samples had no prior knowledge of the contents. According to the
protocol, each laboratory was instructed to isolate DNA from 200 l of each
serum sample, using their routine DNA extraction method. Details of the DNA
extraction procedures and amplification protocols are described in Table 1. DNA
was eluted in 100 l of elution buffer, supplemented with 5 l of bovine serum
albumin (New England Biolabs, Ipswich, MA) to a final concentration of 0.1
mg/ml, and stored at 20°C until further use. All DNA samples were subse-
quently collected by a central laboratory and redistributed among the participat-
ing laboratories for PCR analysis. Each real-time PCR mixture contained 5 l of
DNA extract. PCR analysis of each DNA extract was performed in duplicate, and
thus four PCR results were obtained per original sample. The locations of the
primers and probe combinations used by the participating laboratories are shown
in Fig. 1 and described in Table 2.
All samples were shipped on dry ice using an overnight delivery service. Labora-
tories were instructed to keep the samples frozen until they were processed.
RESULTS
In the first experiment, the analytical sensitivities of the
different real-time PCR procedures were evaluated using nine
samples of 3-fold serial dilutions of DNA extracted from the
Nine Mile strain (RSA493). From each DNA dilution, four
PCR results were obtained per laboratory. A minimum differ-
ence in PCR assay sensitivity was observed between the labo-
ratories when evaluated on a dilution series of genomic DNA
(Table 3). All laboratories were able to demonstrate the pres-
ence of C. burnetii DNA in four out of four replicates in the
first two dilutions. Five laboratories were able to demonstrate
the presence of C. burnetii DNA in at least two out of four
replicates in the fourth dilution step. One laboratory was able
to demonstrate the presence of C. burnetii DNA in three out of
four replicates in the fifth dilution step. Incidentally, a single
positive PCR result was obtained with some of the higher DNA
dilutions, while a lower dilution remained PCR negative. We
TABLE 1. Overview of equipment and protocols used by the participating laboratories
Laboratory DNA extraction platform DNA isolation kit PCR platform PCR reagents Reactionvol (l) Cycling parameters
e
A Manual High Pure viral nucleic acid
kita
LightCycler 480a LightCycler 480
Probe Mastera
20 95°C, 1 s; 60°C, 12 s
(50)
B NucliSens EasyMagb NucliSens magnetic extraction
reagentsb
ABI Prism 7500c In-house master mix 25 95°C, 15 s; 60°C, 1 min
(45)
C MagNA Pure Compact
systema
MagNA Pure Compact
nucleic acid isolation kit Ia
ABI Prism 7500 ABI Universal
Master mixc
25 50°C, 2 min; 95°C,
15 s; 60°C, 1 min
(45)
D MagNA Pure Compact
system
MagNA Pure Compact
nucleic Acid isolation kit I
ABI Prism 7500 ABI Universal
Master mix
25 50°C, 2 min; 95°C,
15 s; 60°C, 1 min
(45)MagNA Pure LC
Systema
MagNA Pure LC total nucleic
acid isolation kita
E Manual QIAamp DNA mini kitd ABI Prism 7500 ABI Universal
Master mix
30 50°C, 2 min; 95°C,
15 s; 60°C, 1 min
(45)
F MagNA Pure Compact
system
MagNA Pure Compact
nucleic acid isolation kit I
LightCycler 480 LightCycler 480
Probe Master
50 95°C, 15 s; 60°C, 1 min
(45)
MagNA Pure LC system MagNA Pure LC total nucleic
acid isolation kit
G Manual QIAamp DNA mini kit LightCycler 480 LightCycler FastStart
DNA Master
HybProbea
20 95°C, 10 s; 60°C, 20 s;
72°C, 15 s (45)
a Roche Diagnostics, Almere, Netherlands.
b bioMerieux, Boxtel, Netherlands.
c Applied Biosystems, Nieuwekerk a/d IJssel, Netherlands.
d Qiagen, Venlo, Netherlands.
e Excluding any initial denaturation or final extension and/or cooling step.
FIG. 1. Location of amplicon with PCR primers and probes from each laboratory (A to G) on the IS1111a insertion element.
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believe that this is the result of the stochastic distribution of the
DNA molecules over these high dilutions.
By the design of the study, we were able to assess the relative
efficiencies of the DNA extraction methods that were used as
well as the sensitivities of the PCR assays being used. These
were evaluated with clinical samples from Q fever patients.
The results are shown in Table 4. For sample A, the percent-
ages of positive PCRs were similar, indicating that all extrac-
tion methods performed equally well on this sample (71 to
89%). All but one of the laboratories were able to produce at
least three out of four positive PCR results. With one excep-
tion, a positive PCR result was obtained in 89 to 97% of
samples across all DNA extraction methods. More variation in
the results was seen with sample B. Depending on the DNA
extraction method used, a positive PCR result was obtained in
25 to 64% across all real-time PCR assays. A positive PCR
result was obtained in 3 to 78% of samples across all DNA
extraction methods. Apparently, the sensitivity of one of the
PCR assays was much lower for both samples on DNA ex-
tracted from clinical samples than those of the other assays
(laboratory G). The PCR assay that was used by laboratories C
and D showed the highest overall sensitivity on DNA extracted
from serum. With one exception (laboratory G), none of the
laboratories obtained a positive PCR result on the negative-
control sample (sample C) (data not shown).
All PCR primers and probes were designed using various
primer and probe design programs targeting the DNA se-
quence of the IS1111a insertion element from the genome of
the Nine Mile strain RSA493 (GenBank accession number
AE016828). More recently, the genomic sequences of four
additional C. burnetii strains, i.e., Dugway (accession number
CP000733), RSA331 (CP000890), CbuG Q212 (CP001019),
and Cbuk Q154 (CP001020), have become available from the
National Center for Biotechnology Information (NCBI) nucle-
otide database (http://www.ncbi.nlm.nih.gov). The insertion el-
ements of these strains may contain polymorphisms that have
not been taken into account in development of the PCR primers
and probes. Since any mismatch between the primer or probe
sequence and the target sequence may lead to less efficient or less
sensitive PCR assays, the suitability of the developed primers and
probes was reassessed in silico using these additionally available
genomic sequences. As it turns out, certain primer and probe
combinations contain mismatches in the target sequences that
may affect the performance of the PCR assays (Table 5).
DISCUSSION
Reliable detection of C. burnetii DNA in serum requires
highly efficient DNA extraction procedures and sensitive PCR
methods. In this study we compared the analytical procedures
that were developed by diagnostic laboratories in the Nether-
lands to aid in identification of patients with Q fever. All PCR
assays targeted the C. burnetii IS1111a element, a multicopy
element that has been reported to be specific for Coxiella
burnetii (2, 7, 16). By the design of this study, we were able to
TABLE 2. Nucleotide sequences of amplification primers and detection probes used in this study.
Laboratory(ies) Formata Primer or probe Concn(M) Sequence (5 3 3) Location
b Amplicon
size (bp) Reference
A TM QKF3 0.5 GTGGTGCCAAGCGATTTTAT 7216–7235 78 This study
QKR3 0.5 GTTTCATCCGCGGTGTTAAT 7293–7274
QKP3 0.2 FAM-TTTAGCGAGCGAAGCGGTGG-TAMRA 7253–7272
B TM QFw 0.9 TGATGGAAGCGTGTGGAGG 6910–6928 87 This study
QRv 0.9 CGTGCTGCGGACTGATCAAC 6996–6977
QProbe 0.2 VIC-GCGAACCATTGGTATCGGACGTTT-TAMRA 6951–6974
C, D TM 456 0.5 AAAACGGATAAAAAGAGTCTGTGGTT 7635–7660 70 13
457 0.5 CCACACAAGCGCGATTCAT 7704–7686
Coxbur 0.15 FAM-AAAGCACTCATTGAGCGCCGCG-TAMRA 7661–7683
E, F TM IS FW 0.5 AAAGTGATCTACACGAGACGGGTTA 6834–6858 75 This study
IS REV 0.5 CACGCAGCCCACCTTAAGAC 6908–6889
PIS 0.2 FAM-CGTGCTCAGTATGTATC-MGB 6861–6877
G HP CbISF-2 0.5 GGACGAAGCGATTGGTGATTAC 7331–7352 202 This study
CbISR-2 0.5 ACTCGAATGTTGTCGAGGG 7532–7514
CbIS1111aFL 0.2 GCGTGGGTGACATTCATCAATTTCATCG-Flu 7453–7480
CbIS1111aCT635 0.2 CFRed635-CCCGGCAGTTGTCGGCGTTTA-PO4 7483–7503
a TM, TaqMan/hydrolysis probe; HP, hybridization probe.
b Location in positions 6684 to 7778 of the whole genome sequence of C. burnetii RSA493 (GenBank accession number AE016828), encoding the transposase gene
of the C. burnetii-specific IS1111a insertion element.
TABLE 3. Number of positive PCRs using a 3-fold serial dilution
series of Nine Mile DNA tested with four replicates
Dilution
(fold)
Approximate copy
no. per DNA
sample (5 l)
No. of positive PCRs in laboratory:
A B C D E F G
9 250 4 4 4 4 4 4 4
27 83 4 4 4 4 4 4 4
81 28 4 4 2 4 3 4 1
243 9.3 2 1 3 2 2 2 1
729 3.1 3 1 0 0 0 1 0
2,187 1.0 1 0 1 0 0 1 1
6,561 0.34 0 1 0 0 1 0 0
19,683 0.11 0 0 0 0 0 0 0
59,049 0.04 0 0 0 0 0 0 0
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separately analyze the performance of the DNA extraction
procedure and of the PCR assays. In this study, we used actual
clinical serum samples containing different loads of C. burnetii
(DNA) instead of serum samples that were spiked with high-
molecular-weight genomic DNA from C. burnetii DNA to get
a more representative measure of the efficiency of the DNA
extraction methods used. Manual extraction procedures per-
formed equally as well as some automated extraction plat-
forms. Despite the fact that most commercial DNA extraction
kits are based on the similar chemistries, the automated
MagNA Pure Compact system and the manual QIAamp DNA
mini kit consistently yielded better results than either the
MagNA Pure LC system and the NucliSens EasyMag (both
automated) or the High Pure viral nucleic acid kit (manual).
Less variation was observed in the sensitivity of the different
PCR assays, with one major exception: the PCR that was in use
in laboratory G was much less sensitive than the other PCR
assays. This PCR performed similarly to the other assays on a
dilution series of high-molecular-weight genomic DNA from
the Nine Mile strain but was less sensitive on DNA extracted
from clinical samples. Unfortunately, insufficient material was
left to confirm these findings. However, there appears to be a
very plausible explanation for these results: the lack in sensi-
tivity may possibly be explained by the significantly larger PCR
product that is targeted by laboratory G (202 bp, versus 70 to
87 bp in the other laboratories). In general cell-free DNA in
serum is very likely to be degraded to a certain extent. There-
fore, short sequences are likely to represent better targets than
larger sequences. The highest overall sensitivity on DNA ex-
tracted from serum was obtained by the PCR assay that was in
use in laboratories C and D. Notably, although the differences
from most other PCR assays were relatively small, this assay
targeted the shortest DNA fragment (70 bp). Another expla-
nation for this difference may reside in sequence polymor-
phisms in the target sequences. All PCR assays were developed
using the IS1111a sequence from the Nine Mile RSA493
strain. Analysis of IS1111a sequences from various other C.
burnetii genomes shows the presence of multiple nucleotide
polymorphisms that may affect PCR performance. Certain
PCR amplification primers or detection probes do not match
the target sequences of certain genomes equally well (Table 5).
Depending on the location of the present mismatch(es), this
may have had a detrimental effect on the performance of the
TABLE 4. Efficiency of DNA extraction methods and sensitivity of real-time PCR assays (tested in quadruplicate)
Sample DNA extraction method (laboratory)
No. of positive results out of 4 PCRs in laboratory: Total %
positiveA B C D E F G
Aa High Pure viral nucleic acid kit (A) 3 4 3 4 3 3 0 71
QIAamp DNA mini kit (E) 4 4 4 4 4 4 1 89
QIAamp DNA mini kit (G) 4 4 4 4 4 4 0 86
NucliSens EasyMag (B) 3 3 4 3 4 3 0 71
MagNA Pure Compact (C) 4 4 4 4 4 4 1 89
MagNA Pure Compact (D) 4 3 4 4 4 4 0 82
MagNA Pure Compact (F) 3 4 4 4 4 4 0 82
MagNA Pure LC system (D) 4 3 4 4 3 3 0 75
MagNA Pure LC system (F) 4 3 4 4 4 4 0 82
Total % positive 92 89 97 97 94 92 6
Bb High Pure viral nucleic acid kit (A) 2 1 2 3 1 0 0 32
QIAamp DNA mini kit (E) 2 1 3 4 3 4 0 61
QIAamp DNA mini kit (G) 1 2 3 4 4 2 0 57
NucliSens EasyMag (B) 1 1 2 0 2 1 0 25
MagNA Pure Compact (C) 3 1 4 4 2 4 0 64
MagNA Pure Compact (D) 1 0 4 3 2 3 1 50
MagNA Pure Compact (F) 2 1 2 4 4 3 0 57
MagNA Pure LC system (D) 0 1 1 2 4 1 0 32
MagNA Pure LC system (F) 1 0 2 4 0 2 0 32
Total % positive 36 22 64 78 61 56 3
a Clinical positive sample with a relatively high DNA load.
b Clinical positive sample with a relatively low DNA load.
TABLE 5. Numbers of IS1111a insertion elements with exact
matches to the primer and probe sequences in the
genomes of five different C. burnetii isolates
Laboratory(ies)
No. of elements in strain (IS1111a copy no.):
RSA493
(20)
Dugway
(12)
RSA331
(47)
CbuG Q212
(28)
CbuK Q154
(48)
A 20 12 43b 28 48
B 20 12 47 28 48
C, D 20 12 47 28 40e
E, F 20 0a 47 28 46f
G 20 12 46c 0d 8g
a This involves a single nucleotide mismatch at the 5 end of the forward
primer.
b This involves various mismatches in both forward and reverse primers in 4 of
the 47 copies of the IS1111a insertion element.
c This involves six mismatches in the reverse primer in 1 of the 47 copies of the
IS1111a insertion element.
d This involves a single nucleotide mismatch at a central position of the 28-
base CbIS1111aFL probe.
e This involves a single nucleotide mismatch at the second position of the
forward primer in 8 of the 48 copies of the IS1111a insertion element.
f This involves a single nucleotide mismatch and a double nucleotide mismatch
in the reverse primer, both in 1 of the 48 copies of the IS1111a insertion element.
g This involves a single nucleotide mismatch at the 5 end of the reverse primer
in 29 of the 48 copies of the IS1111a insertion element and various mismatches
in the reverse primers in another 10 of the 48 copies of the IS1111a insertion
element.
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PCR, especially for those near the 3 end of the primers or
near the 5end of a hydrolysis probe. It has been shown that C.
burnetii genotypes from the Netherlands display a considerable
degree of homogeneity, indicating a clonal origin (6). There-
fore, DNA sequence polymorphisms in the IS1111a elements
in this Dutch clone may also affect the different PCR assays
studied here and may also explain the poor performance of the
PCR used by laboratory G. Whether or not this is a likely
explanation remains to be established. Obviously, in samples
with a very low target concentration, sampling variation may
explain part of the heterogeneity seen in the results from the
dilution series of genomic DNA from the Nine Mile strain
(Table 3). For the evaluation of the performance of the DNA
extraction methods, all participating laboratories analyzed all
of the extracted DNA samples, and any effect of sampling
variation on the interpretation of the results would be mini-
mized. Two different real-time PCR platforms were used by
the participating laboratories (LightCycler 480 or ABI Prism
7500). Although this could have contributed to differences in
sensitivities for the various assays, in the context of the results
presented in Table 3 and the alternative explanations for the
lower sensitivity of the assay used by laboratory G, this appears
unlikely to be a contributing factor.
In conclusion, we show that multiple combinations of DNA
extraction kits and real-time PCR assays offer equivalent solu-
tions for the screening of patients suspected to have Q fever.
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